BMC Nephrol
Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series.
de Nattes T, Moreau-Grangé L, Vezzosi D, Haddoux J, Hie M, Guerrot D, Grangé S
Cancer-related thrombotic microangiopathy (CR-TMA) is a rare entity associated with a dismal prognosis. Usually, CR-TMA is associated with mucin-produ ...
Read More
Source: PubMed
Dis. Markers
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Liang J, Liu Z, Pei T, Xiao Y, Zhou L, Tang Y, Zhou C, Wu K, Zhang F, Zhang F, Yin X, Chen N, Wei X, Lu Y, Zhu Y
Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumor with a high tumor recurrence rate and poor postoperative survival. Recent studies s ...
Read More
Source: PubMed
Invest New Drugs 2020 Jan 27
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Smith DC, Kroiss M, Kebebew E, Habra MA, Chugh R, Schneider BJ, Fassnacht M, Jafarinasabian P, Ijzerman MM, Lin VH, Mohideen P, Naing A
Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with very limited treatment options. Nevanimibe HCl (formerly ATR-101), ...
Read More
Source: PubMed
Case Rep Urol
Robot-Assisted Laparoscopic Adrenalectomy for Rare Myxoid Adrenocortical Carcinoma.
Johnson G, Thalody K, Kapur U, Nguyen TT
Surgical resection remains the standard treatment for adrenocortical carcinoma. Higher rates of local and peritoneal recurrence have been reported wit ...
Read More
Source: PubMed
BMC Nephrol
Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series.
de Nattes T, Moreau-Grangé L, Vezzosi D, Haddoux J, Hie M, Guerrot D, Grangé S
Cancer-related thrombotic microangiopathy (CR-TMA) is a rare entity associated with a dismal prognosis. Usually, CR-TMA is associated with mucin-produ ...
Read More
Source: PubMed
Dis. Markers
Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma.
Liang J, Liu Z, Pei T, Xiao Y, Zhou L, Tang Y, Zhou C, Wu K, Zhang F, Zhang F, Yin X, Chen N, Wei X, Lu Y, Zhu Y
Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumor with a high tumor recurrence rate and poor postoperative survival. Recent studies s ...
Read More
Source: PubMed
Invest New Drugs 2020 Jan 27
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Smith DC, Kroiss M, Kebebew E, Habra MA, Chugh R, Schneider BJ, Fassnacht M, Jafarinasabian P, Ijzerman MM, Lin VH, Mohideen P, Naing A
Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with very limited treatment options. Nevanimibe HCl (formerly ATR-101), ...
Read More
Source: PubMed
Case Rep Urol
Robot-Assisted Laparoscopic Adrenalectomy for Rare Myxoid Adrenocortical Carcinoma.
Johnson G, Thalody K, Kapur U, Nguyen TT
Surgical resection remains the standard treatment for adrenocortical carcinoma. Higher rates of local and peritoneal recurrence have been reported wit ...
Read More
Source: PubMed
